Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ISRCTN12749687) titled 'Repeat surgery for recurrent glioblastoma' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Open (masking not used)
Control: Active
Assignment: Parallel
Purpose: Treatment
Primary Sponsor: University of Oxford
Condition:
Repeat surgery for patients with recurrent glioblastoma
Cancer
Intervention:
This is a two-arm, pragmatic randomised controlled trial in adults with recurrent glioblastoma (GB). Participants will be followed for a maximum of 12 months from randomisation.
Intervention arm: Repeat maximal safe resection followed by second-line medical th...